DOT-cells (Lymphocyte Activation Technologies)

N/A

Report date: 2025/01/15 20:00:32

Base Information

Drug NameDOT-cells (Lymphocyte Activation Technologies)
Drug Alias NameDOT-cells
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsOvarian NeoplasmsPancreatic NeoplasmsColonic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugal
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLymphocyte Activation Technologies SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGammaDelta Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsPancreatic NeoplasmsColonic Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A